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ABSTRACT
Chronic obstructive pulmonary disease (COPD) is strongly associated with 
progressive airway limitation where the key mechanism is abnormal airway 
remodelling of bronchial mucosa maintained by complex crosstalk of tissue 
remodelling and regulatory factors. The aim of this study was to determine 
the appearance and local distribution of tissue remodelling factors in COPD-
affected lung tissue and to compare the findings with the control group. In 
this study, lung tissue specimens were obtained from 27 patients with COPD 
and 49 control patients. Tissue samples were examined by routine hematoxy-
lin and eosin staining. Remodelling and regulatory factors matrix metallopro-
teinase-2 (MMP-2), tissue inhibitor of metalloproteinase-2 (TIMP-2), trans-
forming growth factor-β1 (TGF-β1), as well as heat shock protein-70 (Hsp-70) 
were detected by immunohistochemistry in airway mucosa. The numbers of 
positive structures were evaluated semiquantitatively. Non-parametrical sta-
tistical analysis was performed. Overall COPD-affected lung tissue presented 
chronic inflammation and tissue remodelling in routine histological analysis. 
Compared to the control group, statistically significant (P<0.05) difference 
was calculated between COPD affected lung tissue and control group with 
overall more immunoreactive cells containing MMP-2, TIMP-2 and TGF-β1 
and less Hsp-70 immunoreactive bronchial epithelial cells, subepithelial con-
nective tissue fibroblasts, bronchial smooth muscle cells and secretory cells 
of bronchial glands with more pronounced findings of TGF-β1, however, 
less Hsp-70. Study findings suggest pronounced tissue damage and remodel-
ling with the local regulatory environment of up-regulated TGF-β1. Increased 
numbers of MMP-2, TIMP-2 and TGF-β1 immunoreactive cells suggest the 
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key role of these remodelling factors in COPD pathogenesis. Decrease of 
 Hsp-70 proves increased cell damage in COPD-affected airway mucosa.
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INTRODUCTION
Chronic obstructive pulmonary disease (COPD) is a chronic infl ammatory 
lung disease that causes obstructed airfl ow through the lung airways. In COPD, 
mostly the pathogenic triad of chronic infl ammation, altered and disrupted 
remodelling, as well as oxidative stress correspond to the cytopathology and 
histopathology [6]. Altered infl ammatory response, cell and tissue damage, also 
abnormal repair of cell and tissue injury confi rms defective remodelling of the 
extracellular matrix (ECM) in lung airways. ECM in airways is composed of 
matrix proteins, as well as molecular environment modifying molecules like 
matrix metalloproteinases (MMPs), growth and regulatory factors and signal-
ling molecules [18]. Matrix metalloproteinase 2 (MMP-2) from the gelati-
nase family strongly aff ects the ECM components in tissue remodelling, as 
well as connective tissue cell migration and wound healing that might lead 
to fi brosis [14]. Tissue inhibitors of metalloproteinases (TIMPs) are acting as 
direct inhibi tors of MMPs; moreover, TIMPs like tissue inhibitor of metal-
loproteinase 2 (TIMP-2) promote cell growth and protect cells from apop-
tosis. TIMPs not only aff ect tissue remodelling, but also shape and organize 
appropriate ECM environment and architecture. Increased levels of TIMPs 
promote ECM accumu lation towards fi brosis, whereas the decrease of TIMPs 
enhances proteolysis in ECM. TIMPs regulate MMPs within ECM by inhib-
iting their maintenance [1, 6, 7]. Overall eff ective ECM remodelling in lung 
tissue is regulated as a dynamic balance between the proper cell and tissue 
renewal and, conversely, the tissue degradation. In COPD, airway remodelling 
occurs as a resistance response to the cigarette smoking induced damage to 
airway cells and tissues [16]. Tissue remodelling aspect of COPD pathogenesis 
in molecular level predominantly contributes by an imbalance of proteolytic 
and antipro teolytic mechanisms with pathological ECM degradation or contro-
versially, ECM deposition [6]. Extensive production of ECM components with 
 imbalance of MMPs and TIMPs to build remodelled tissue is evaluated as 
crucial in COPD pathogenesis with activated bronchial epithelium that further 
triggers subepithelial connective tissue to promote airway fi brosis with rapid 
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diff erentiation of fi broblasts into myofi broblasts [9, 17]. Remodelling of central 
airways in COPD due to the increased deposition of ECM proteins, as well as 
an increase of smooth muscle cell area leads to airway obstruction initiating 
luminal narrowing [9]. Th e transforming growth factor β1 (TGF-β1) is the 
most abundant member of the transforming growth factor (TGF) family in 
lung tissue. TGF-β1 promotes the secretion and deposition of ECM proteins by 
airway fi broblasts and myofi broblasts [9, 11]. Secretion of TGF-β1 by injured 
epithelial cells induces airway epithelial wound repair and further subepithelial 
ECM remodelling [4]. 70-kDa heat shock protein (Hsp-70) is intracellularly 
located molecular chaperone with regulatory role of extracellular chemokine 
production infl uencing both normal innate immunity responses and infl am-
matory signalling [5]. Synthesis of Hsp-70 is upregulated during diff erent 
stresses (physical or chemical stress), especially during oxidative stress, thus 
it maintains protective eff ects against cell and tissue damage universally in 
human tissue [13]. Reactive oxygen species (ROS) as oxidative stress stimuli 
promoted by cigarette smoking could mediate cell and tissue alterations, as well 
as cell senescence in COPD. ROS also interact with proteases and antiproteases 
then triggering the imbalance of both. Hsp-70 as oxidative stress biomarker 
therefore could contribute in COPD pathogenesis within oxidative injury [6]. 
Although many molecular signalling pathways are studied in COPD patho-
genesis, they eventually fail leading to abnormal and altered cell crosstalk, regu-
lation and adaption. Th us, the aim of this study was to explore the appearance 
and local distribution of tissue remodelling and regulatory factors in COPD-
aff ected lung tissue. 
MATERIALS AND METHODS
COPD-aff ected lung tissue specimens were obtained during fi brobronchoscopy 
from 27 patients aged from 53 to 85. Th e diagnosis of COPD was assessed 
by both clinical criteria and during bronchoscopy. Th e lung tissue material 
of the control group was obtained during autopsy from 49 relatively healthy 
study subjects aged from 9 to 95 years. Th e study was approved by the Ethical 
Committee of Pauls Stradiņš Clinical University Hospital (23 January 2013). 
Tissue sections (5 μm) were cut to proceed to routine histological staining with 
hematoxylin and eosin. All lung tissue specimens were examined by bright 
fi eld light microscopy. Tissue remodelling and regulatory markers were studied 
using the biotin-streptavidin immunohistochemistry (IHC) method. Primary 
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antibodies of MMP-2 (R&D Systems, Germany), TIMP-2 (Santa Cruz Biotech-
nology, USA), TGF-β1 (Biorbyt, UK), and Hsp-70 (Invitrogen, Italy) were used 
in this study. Th e appearance and distribution of immunoreactive (positive) 
cells was evaluated semi-quantitatively [12], counting the relative number of 
positive epithelial cells, mucosal fi broblasts, glandulocytes, bronchial smooth 
muscle cells and capillary endothelial cells. Th e following scale of semi-quan-
titative method was used, grading the positive cells seen in the visual fi eld at 
×400 magnifi cation: 0 – no positive cells, 0/+ – occasional, + – few, +/++ – few 
to moderate number, ++ – moderate number, ++/+++ – moderate number to 
numerous, +++ – numerous, +++/++++ – numerous to abundance, ++++ – 
abundance of positive cells. To perform statistical analysis, nonparametric 
statistical methods – Mann-Whitney U test and Spearman’s rank-order corre-
lation – were used. All data were categorized in ordinal ranking as ordinal 
values, where the ranking system of nine ranks was applied from the value of 
0 (no positive structures (0)), the value 0.5 (occasional positive cells (0/+)), et 
cetera to the value of 4.0 (abundance (++++)). 
RESULTS
In routine histological analysis, COPD-aff ected lung tissue presented various 
degrees of chronic infl ammation and tissue remodelling. We evidenced goblet 
cell hyperplasia (Fig. 1A), bronchial epithelial squamous metaplasia, subepi-
thelial basement membrane thickening, airway fi brosis with thick connective 
tissue collagen bundles, bronchial gland hypertrophy and hyperplasia (Fig. 1B), 
bronchial microvasculature remodelling, smooth muscle cell hyperplasia and 
hypertrophy, remarkable infl ammatory cell infi ltration in airway mucosa and 
submucosa, and glandular tissue. 
Th e numbers of MMP-2 positive cells varied from no positive cells (0) in the 
connective tissue, bronchial glands, smooth muscles and in the endothelium 
to abundance (++++) of positive cells in the bronchial epithelium (Table 1). 
Overall, the appearance of MMP-2 immunoreactive cells was evaluated as 
highest in the bronchial epithelium and connective tissue, however, we found 
fewer MMP-2 positive cells in the bronchial smooth muscle. Th e numbers 
of TIMP-2 immunoreactive cells were estimated ranging from no positive 
cells (0) in the bronchial glands reaching the maximum value of abundance 
(++++) of cells in the bronchial epithelium and from numerous to abun-
dance (+++/++++) of TIMP-2-containing cells in the connective tissue and 
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Figure1. Representative microphotographies examined by routine histological staining 
with hematoxylin and eosin (A, B) and detection of remodelling factors MMP-2 and 
Hsp-70 by use of the immunohistochemistry (IMH) method (C – F). (A) Goblet cell hyper-
plasia of bronchial epithelium in bronchus wall of a 64-year-old male (COPD). Hematoxylin 
and eosin, X200. (B) Bronchial gland hypertrophy and hyperplasia, smooth muscle hyper-
trophy in large bronchus wall of a 60-year-old-male (COPD). Hematoxylin and eosin, X200. 
(C) Few to moderate number (+/++) of MMP-2 positive bronchial epithelial cells of large 
bronchus wall in an 81-year-old female (control). MMP-2 IMH, X100. (D) Numerous to abun-
dance (+++/++++) of MMP-2 positive epithelial cells in bronchial epithelium with squa-
mous epithelial metaplasia in a 60-year-old male (COPD). MMP-2 IMH, 100x. (E) Abundance 
(++++) of Hsp-70 immunoreactive bronchial epithelial cells in bronchus wall of an 81-year-
old female (control). Hsp-70 IMH, X100. (F) Occasional (0/+) Hsp-70 positive bronchial 
epithelial cells in bronchus wall of a 72-year-old male (COPD). Hsp-70 IMH, X200. 
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the endothelium. In summary, we found the most of TIMP-2 immunoreactive 
cells in the bronchial epithelium and fewer in the bronchial smooth muscle. 
Moreover, immunohistochemistry fi ndings of TIMP-2 were more pronounced 
when compared to MMP-2 results in all the examined tissues. Th e appearance 
and distribution of TGF-β1 varied from no positive (0) TGF-β1 containing 
smooth muscle cells to abundance (++++) of TGF-β1 containing bronchial 
epithelial cells and subepithelial connective tissue fi broblasts. Overall, the 
higher numbers of TGF-β1 immunoreactive cells were found in the bron-
chial epithelium and connective tissue and somewhat fewer in the bronchial 
glands, endothelium and among the bronchial smooth muscle cells. In contrast 
to MMP-2, TIMP-2, TGF-β1, we found particularly few Hsp-70-containing 
immunoreactive cells with the range of no positive (0) cells in all the examined 
tissues to few (+) Hsp-70 positive bronchial smooth muscle cells. Interestingly, 
we found overall more pronounced numbers of bronchial epithelial cells and 
fewer Hsp-70 positive endothelial cells with the estimation of mostly occa-
sional (0/+) numbers of cells. 
Compared to the control group, Mann-Whitney U-test showed a statisti-
cally signifi cant (P<0.05) diff erence between COPD-aff ected lung tissue and 
the control group with overall more immunoreactive cells in all the examined 
tissues of bronchial epithelium, subepithelial connective tissue, bronchial 
glands, small capillary endothelium and bronchial smooth muscle containing 
more MMP-2 (Fig. 1C, Fig. 1D), TIMP-2 and TGF-β1 and fewer Hsp-70 (Fig. 
1E, Fig. 1F) immunoreactive cells. With large eff ect size r calculated (> 0.7) to 
specify Mann-Whitney U test results, COPD-aff ected lung tissue is more likely 
to evidence an increased number of MMP-2, TIMP-2 and TGF-β1 immuno-
reactive cells. Bronchial epithelial cells, subepithelial connective tissue fi bro-
blasts, bronchial smooth muscle cells and endothelial cells indicated more 
pronounced fi ndings of TGF-β1, however, fewer Hsp-70 immunoreactive 
bronchial epithelial cells compared to the normal control group (Table 1). 
DISCUSSION
In COPD-aff ected lung tissue, MMP-2 immunoreactive cells were ranked 
higher in bronchial epithelium and subepithelial connective tissue (median 
values 3.0 and 2.0, respectively). Th ese fi ndings suggest COPD tissue is more 
likely to evidence an increase of MMP-2 in these compartments of the bron-
chial mucosa compared to the healthy control group. In COPD patients with 
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the background of cigarette smoking, air-derived irritants might harm the 
epithelial tissue and initiate infl ammation with attracting immune cells and 
activating proteolytic environment with the predominance of collagenase 
MMP-2. Furthermore, degraded extracellular matrix (ECM) fragments might 
act as local chemokines and promote local infl ammation [2]. MMP-2 gene 
expression is induced by cigarette smoke in normal lung connective tissue 
fi broblasts [17]. Also in COPD-aff ected lung tissue, lung fi broblasts show 
induced MMP-2 protein expression, as well as increased MMP-2 gelatinase 
activity against ECM [10]. Immunoreactivity, protein expression, gelatino-
lytic activities of MMP-2 was markedly increased in epithelial cells, fi broblasts 
and endothelial cells in COPD suggesting up-regulation of MMP-2 [8]. Also, 
when compared to the control group, the medium eff ect size (0.5 < r < 0.7) was 
calculated for MMP-2 immunoreactive bronchial epithelial cell and connective 
tissue fi broblasts suggesting their increased role in COPD development. 
Similarly to the fi ndings of MMP-2, we found more pronounced TIMP-2 
appearance in bronchial epithelium and connective tissue; moreover, high 
numbers of immunoreactive TIMP-2 endothelial cells were also found (median 
values 3.0, 2.5 and 2.0, respectively). To maintain the stability of ECM envi-
ronment, TIMP-2 directly inhibits MMP-2; therefore, the location of TIMP-2 
is crucial. Aft er the release, both active form and pro-active form of MMPs 
are regulated by the activity of TIMPs [1]. In COPD, imbalance of proteases 
(MMPs) and antiproteases (TIMPs) induces structural changes in the form of 
pathological tissue repair and airway remodelling [17]. In our study, we might 
support this opinion of TIMP-2 predominance over MMP-2 with its regula-
tory role in airway remodelling. Moreover, these fi ndings might suggest the 
background of airway fi brosis that we estimated as ECM depositions with thick 
collagen fi bre bundles in our patients.
Compared to all other examined remodelling and regulatory factors, 
we counted more TGF-β1 immunoreactive cells in all the examined tissue 
compartments (median values were ranging from 2.0 to 3.0) of COPD-aff ected 
bronchial mucosa with more pronounced fi ndings in the bronchial epithe-
lium. When stimulated with TGF-β1, airway basal epithelial cells might lead 
the whole bronchial epithelium to squamous metaplasia and goblet cell hyper-
plasia or contribute to airway fi brosis through epithelial to mesenchymal tran-
sition [15]. Th e background then of fi brosis in airways is master regulation of 
TGF-β1 with the consequences of pseudostratifi ed epithelial to mesenchymal 
transition, as well as fi broblast to myofi broblast and even smooth muscle cell 
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to myofi broblast transition [9]. TGF-β1 release based on oxidant-mediated 
mechanisms confi rms the activating role of oxidative stress [3, 9]. In our study, 
the most pronounced site of TGF-β1 was exactly bronchial epithelium. Since 
the epithelium is aff ected by cigarette smoke fi rst, epithelial cells must tolerate 
oxidative injury with an increased release of regulatory molecules suggesting 
their protective role. Airway epithelium, activated smooth muscle, fi bro-
blasts and myofi broblasts are important sources of TGF-β1, moreover, with a 
powerful eff ect on tissue remodelling [7]. TGF-β1 exerts a protective role by 
struggling to maintain lung tissue homeostasis in physiological conditions that 
are usually lost in COPD [3].
In all the examined tissue compartments, we found fewer or similar 
numbers of Hsp-70 immunoreactive cells overall and compared to the 
control group. Th e examined cells were mostly negative (0) for Hsp-70 immu-
nostaining, however, reaching only occasional (median value 0.5) numbers 
of bronchial epithelial cells that had the highest values in the COPD group. 
In the control tissue, the numbers of Hsp-70 immunoreactive cells were few 
to moderate (median value 1.5) in the bronchial epithelium and occasional 
(median value 0.5) in the bronchial connective tissue and bronchial glands. 
Although Hsp-70 maintains the protective role against cytotoxic damage and 
it is up-regulated under physical and chemical stress stimuli, abnormal Hsp-70 
expression might occur if prolonged stress stimuli keep cellular and tissue 
stress response. When chronic cigarette smoking occurs, long-term oxidative 
stress might cause oxidative damage due to accumulation of oxidative prod-
ucts in airway tissue [13]. Adaption to chronic oxidative stress occurs through 
down-regulation of Hsp-70. Moreover, short-time exposure of cigarette smoke 
initiates an increased expression of Hsp-70. Conversely, long-term exposure 
caused dramatically decreased expression of Hsp-70, genotoxicity altogether 
with DNA damage, cell and tissue injury [19]. 
In conclusion, the wide distribution and extensive appearance of MMP-2, 
TIMP-2, TGF-β1, and Hsp-70 proposes pronounced tissue damage and 
remodelling with the local regulatory patterns of increased TGF-β1. Increased 
numbers of MMP-2, TIMP-2 and TGF-β1 immunoreactive cells suggest the key 
role of these remodelling factors in COPD pathogenesis. Decrease of Hsp-70 
proves its impaired function and increased cell damage in COPD aff ected lung 
tissue.
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